BAYLOR COLLEGE OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
Pharmacogenetics of Doxazosin for Cocaine Dependence
- First Posted Date
- 2010-06-16
- Last Posted Date
- 2019-07-22
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 96
- Registration Number
- NCT01145183
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-04-22
- Last Posted Date
- 2019-04-25
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 16
- Registration Number
- NCT01109095
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
Test of an Intervention to Improve HIV Care
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-04-15
- Last Posted Date
- 2016-06-22
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 460
- Registration Number
- NCT01103856
- Locations
- 🇺🇸
Ben Taub General Hospital, Houston, Texas, United States
Bladder Cancer Patient-Reported Outcomes
Completed
- Conditions
- First Posted Date
- 2010-03-22
- Last Posted Date
- 2016-11-09
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 108
- Registration Number
- NCT01090388
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Rivastigmine as a Treatment for Methamphetamine Dependence
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-02-23
- Last Posted Date
- 2012-07-27
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 17
- Registration Number
- NCT01073319
- Locations
- 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States
Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-02-18
- Last Posted Date
- 2014-09-04
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 10
- Registration Number
- NCT01070797
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
NAC as a Potential Treatment for Methamphetamine Dependence
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-02-05
- Last Posted Date
- 2012-07-27
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 10
- Registration Number
- NCT01063205
- Locations
- 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States
The Effects of Doxazosin on the Cardiovascular and Subjective Effects of Cocaine
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-02-04
- Last Posted Date
- 2012-07-27
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 13
- Registration Number
- NCT01062945
- Locations
- 🇺🇸
Michael Debakey VA Medical Center, Houston, Texas, United States
Investigation of Cycloserine as a Smoking Cessation Treatment
- First Posted Date
- 2010-02-04
- Last Posted Date
- 2012-07-27
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 34
- Registration Number
- NCT01062932
- Locations
- 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States
An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-02-04
- Last Posted Date
- 2022-04-26
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 80
- Registration Number
- NCT01062451
- Locations
- 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath